You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Harvard Business School
Medtronic
Moodys
Express Scripts

Last Updated: September 29, 2023

Drug Price Trends for CLINDAMYCIN


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for CLINDAMYCIN

Average Pharmacy Cost for CLINDAMYCIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CLINDAMYCIN PHOSPHATE 1% GEL 73473-0302-75 5.28024 ML 2023-09-20
CLINDAMYCIN PH 1% GEL 73473-0300-60 0.27557 GM 2023-09-20
CLINDAMYCIN PH 1% GEL 73473-0300-30 0.32762 GM 2023-09-20
CLINDAMYCIN PH 1% SOLUTION 72578-0084-03 0.21314 ML 2023-09-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for CLINDAMYCIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
CLINDAMYCIN PO4 1% LOTION,TOP Sandoz, Inc. 00168-0203-60 60GM 89.77 1.49617 GM 2023-08-15 - 2028-08-14 FSS
CLINDAMYCIN PO4 2% CREAM, VAG Sandoz, Inc. 00168-0277-40 40GM 54.65 1.36625 GM 2023-08-15 - 2028-08-14 FSS
CLINDAMYCIN PO4 1% SOLN,TOP Sandoz, Inc. 00168-0201-60 60GM 21.11 0.35183 GM 2023-08-15 - 2028-08-14 FSS
CLINDAMYCIN PO4 1% GEL,TOP Sandoz, Inc. 00168-0202-30 30GM 37.70 1.25667 GM 2023-08-15 - 2028-08-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Dow
Mallinckrodt
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.